Literature DB >> 6965595

High-dose thymidine infusions in patients with leukemia and lymphoma.

D W Kufe, P Beardsley, D Karp, L Parker, A Rosowsky, G Canellos, E Frei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6965595

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  11 in total

1.  Sensitization of C6 glioma to carboplatin cytotoxicity by hyperthermia and thymidine.

Authors:  J D Cohen; H I Robins; M J Javid
Journal:  J Neurooncol       Date:  1990-08       Impact factor: 4.130

2.  Inhibition of Nucleotide Synthesis Targets Brain Tumor Stem Cells in a Subset of Glioblastoma.

Authors:  Dan R Laks; Lisa Ta; Thomas J Crisman; Fuying Gao; Giovanni Coppola; Caius G Radu; David A Nathanson; Harley I Kornblum
Journal:  Mol Cancer Ther       Date:  2016-03-29       Impact factor: 6.261

3.  A phase I-II study of combination therapy with thymidine and cytosine arabinoside.

Authors:  R Fram; P Major; E Egan; P Beardsley; D Rosenthal; D Kufe
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

4.  Thymidine enhancement of methotrexate and 5-fluorouracil toxicity in cultured human colon carcinoma.

Authors:  C Benz; M Choti; L Newcomer; E Cadman
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

5.  Effect of deoxycytidine on the in vitro response of human leukemia cells to inhibitors of de novo pyrimidine biosynthesis.

Authors:  K Bhalla; S Grant
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 6.  Thymidine as an anticancer agent, alone or in combination. A biochemical appraisal.

Authors:  P H Ellims
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

7.  Clinical use of thymidine as a rescue agent from methotrexate toxicity.

Authors:  J L Grem; S A King; J M Sorensen; M C Christian
Journal:  Invest New Drugs       Date:  1991-08       Impact factor: 3.850

8.  Nucleoside salvage pathway kinases regulate hematopoiesis by linking nucleotide metabolism with replication stress.

Authors:  Wayne R Austin; Amanda L Armijo; Dean O Campbell; Arun S Singh; Terry Hsieh; David Nathanson; Harvey R Herschman; Michael E Phelps; Owen N Witte; Johannes Czernin; Caius G Radu
Journal:  J Exp Med       Date:  2012-11-12       Impact factor: 14.307

9.  Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradication.

Authors:  David A Nathanson; Amanda L Armijo; Michelle Tom; Zheng Li; Elizabeth Dimitrova; Wayne R Austin; Julian Nomme; Dean O Campbell; Lisa Ta; Thuc M Le; Jason T Lee; Ryan Darvish; Ari Gordin; Liu Wei; Hsiang-I Liao; Moses Wilks; Colette Martin; Saman Sadeghi; Jennifer M Murphy; Nidal Boulos; Michael E Phelps; Kym F Faull; Harvey R Herschman; Michael E Jung; Johannes Czernin; Arnon Lavie; Caius G Radu
Journal:  J Exp Med       Date:  2014-02-24       Impact factor: 14.307

10.  ATR inhibition facilitates targeting of leukemia dependence on convergent nucleotide biosynthetic pathways.

Authors:  Thuc M Le; Soumya Poddar; Joseph R Capri; Evan R Abt; Woosuk Kim; Liu Wei; Nhu T Uong; Chloe M Cheng; Daniel Braas; Mina Nikanjam; Peter Rix; Daria Merkurjev; Jesse Zaretsky; Harley I Kornblum; Antoni Ribas; Harvey R Herschman; Julian Whitelegge; Kym F Faull; Timothy R Donahue; Johannes Czernin; Caius G Radu
Journal:  Nat Commun       Date:  2017-08-14       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.